ASPIRIN; DIPYRIDAMOLE | A206392 | AMNEAL PHARMACEUTICALS OF NEW YORK LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. AMNEAL PHARMACEUTICALS LLC 1 patentANDA 206392dipyridamole and acetylsalicylic acid | D.N.J. | 2014-07-30 | Terminated 2015-01-26 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.5727
per ea
Lowest NADAC/Unit
$0.5727
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 65162059606ASPIRIN-DIPYRIDAM ER 25-200 MG | $0.5727 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.